Tranquility Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,830
Closed -$344K 203
2022
Q2
$344K Sell
3,830
-22
-0.6% -$2.23K 0.18% 140
2022
Q1
$427K Buy
3,852
+424
+12% +$44.8K 0.2% 126
2021
Q4
$355K Sell
3,428
-35
-1% -$4.05K 0.16% 142
2021
Q3
$434K Buy
3,463
+327
+10% +$42.3K 0.22% 123
2021
Q2
$389K Buy
3,136
+80
+3% +$10K 0.22% 123
2021
Q1
$361K Buy
3,056
+190
+7% +$22.3K 0.22% 123
2020
Q4
$336K Buy
+2,866
New +$316K 0.24% 111

Other funds holding MDT

Tranquility Partners's MDT Position: Q3 2022 in Review

Tranquility Partners sold out of Medtronic (MDT) in Q3 2022, closing a stake of 3,830 shares — an estimated $344K sold.

Tranquility Partners first reported a position in MDT in Q4 2020 and held it in 7 quarters. The position peaked at $434K in Q3 2021. 1,932 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Tranquility Partners reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Tranquility Partners sold 3,830 Medtronic shares in Q3 2022, an estimated $344K.
  • Tranquility Partners first reported a position in Medtronic in Q4 2020 and held it in 7 quarters.
  • Tranquility Partners's Medtronic position peaked at $434K in Q3 2021.
  • 1,932 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Tranquility Partners's 13F filing for Q3 2022, filed 1 Nov 2022.